NSIS B — Novozymes A/S Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsSpeculativeLarge CapHigh Flyer

Annual income statement for Novozymes A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	14,374	14,012	14,951	17,553	17,899
Cost of Revenue
Gross Profit	7,987	7,853	8,638	9,577	9,722
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	10,335	10,360	10,944	12,725	13,921
Operating Profit	4,039	3,652	4,007	4,828	3,978
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	3,799	3,521	3,924	4,556	3,909
Provision for Income Taxes
Net Income After Taxes	3,155	2,826	3,145	3,686	3,039
Minority Interest
Net Income Before Extraordinary Items
Net Income	3,154	2,825	3,146	3,676	3,024
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	3,154	2,825	3,146	3,676	3,024
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	9.92	9.9	11	12.1	12.2
Dividends per Share